Cancer diagnostics News and Research

RSS

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.

25 Nov 2015

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy

A University of Colorado Cancer Center study published in the journal Breast Cancer Research and Treatment shows that breast cancer patients whose health insurance plans included prescription drug benefits were 10 percent more likely to start important hormonal therapy than patients who did not have prescription drug coverage.

19 Nov 2015

Living with lung cancer: an interview with Aoife McNamara

Understanding how lung cancer affects patients from a social perspective is vital. People living with lung cancer, lung cancer survivors and carers are impacted by lung cancer in different ways.

18 Nov 2015

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.

18 Nov 2015

New RNA test of blood platelets can be used to detect location of cancer

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy. This according to a study at Umeå University in Sweden recently published in the journal Cancer Cell.

12 Nov 2015

Research opens door for developing biomarker tests to detect cancers early

Biomarkers, which allow diseases to be diagnosed and staged based on relatively non-invasive blood tests, have been identified for several types of cancers, but for most cancers remain elusive. Now, research conducted at the RIKEN Center for Life Science Technologies in Japan and the Harry Perkins Institute of Medical Research in Australia has identified a large number of genes that are upregulated in many different types of cancer, opening the door for developing biomarker tests that could be used to detect cancers early, allowing for prompt treatment.

10 Nov 2015

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

With cancer survival rates in the UK persistently trailing comparable European countries, it’s time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.

6 Nov 2015

Differences in vitamin D status may account for disparities in breast cancer survival rates

The American Cancer Society just published a paper reporting that while breast cancer incidence rates for 2008-2012 were similar for black and white women, death rates were 42% higher for black women [DeSantis, 2015]. The factors suggested to explain the disparity in mortality rates included difference in stage at diagnosis, obesity, comorbidities, tumor characteristics, as well as access, adherence, and response to treatments.

5 Nov 2015

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Authors of a meta-analysis question the accuracy of urinary biomarkers for diagnosing the initial incidence or recurrence of bladder cancer.

4 Nov 2015

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges.

4 Nov 2015

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Pancreas cancer remains one of the deadliest cancers worldwide. In the United States, it accounts for only three percent of all diagnosed cancers but it causes almost seven percent of all cancer deaths. A pancreas cancer diagnosis often comes after age 50 and after the cancer has spread, making it difficult to remove surgically.

4 Nov 2015

Findings provide a step towards personalized cancer therapy

Oxford University researchers have found the Achilles heel of certain cancer cells - mutations in a gene called SETD2. Their findings will be presented to the National Cancer Research Institute conference in Liverpool this Monday (2 Nov 15).

2 Nov 2015

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.

31 Oct 2015

Women with elevated breast cancer risk can benefit from regular physical activity

Regular physical activity could play a role in helping women at high-risk of breast cancer delay the need for drastic preventive measures such as prophylactic mastectomy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.

30 Oct 2015

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

The ‘two week wait’ referral was brought into England in 2000. If a patient goes to see their GP and they meet specific criteria that cause the GP to think they might have cancer, then they should be referred to see a specialist within two weeks.

28 Oct 2015

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Researchers studying two generations of a family affected by pediatric acute lymphoblastic leukemia (ALL) have identified an inherited variation in the ETV6 gene that is associated with an increased risk of developing the disease. St. Jude Children's Research Hospital investigators led the study, which appears in the October 28 issue of the journal Lancet Oncology.

28 Oct 2015

Study uncovers new genetic variants linked to increased risk of testicular cancer

A new study of more than 25,000 men has uncovered four new genetic variants associated with increased risk of testicular cancer.

27 Oct 2015

UW researcher reveals how cancer diagnosis affects employment, income of individuals and families

A new analysis by University of Wyoming researcher Anna Zajacova indicates that when American adults are diagnosed with cancer, they experience significant decreases in the probability of working, in the number of hours they work and, correspondingly, in their incomes.

26 Oct 2015

Study describes successful intervention to decrease breast cancer screening anxiety

Recent American Cancer Society breast cancer screening guidelines consider the anxiety created by false-positive mammography an "important but not critical outcome" when deciding who should be screened. In other words, in these guidelines, the chance that mammography will create needless cancer worry is a light thumb on the scale against breast cancer screening in some populations.

23 Oct 2015

University of Warwick, SYSUCC sign MoU to create cancer research partnership

The University of Warwick and Sun Yat-sen University Cancer Center have signed a Memorandum of Understanding (MoU) to create a research partnership in cancer diagnosis and specialist cancer care.

22 Oct 2015

Cancer diagnostics News and Research

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Uninsured, low-income breast cancer patients less likely to continue hormonal therapy

Living with lung cancer: an interview with Aoife McNamara

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

New RNA test of blood platelets can be used to detect location of cancer

Research opens door for developing biomarker tests to detect cancers early

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Differences in vitamin D status may account for disparities in breast cancer survival rates

Urinary biomarkers for bladder cancer diagnosis fall short of mark

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Findings provide a step towards personalized cancer therapy

RNA profiles of tumor-educated platelets may diagnose cancer, identify potential therapeutic approaches

Women with elevated breast cancer risk can benefit from regular physical activity

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Researchers identify inherited gene variation associated with pediatric acute lymphoblastic leukemia

Study uncovers new genetic variants linked to increased risk of testicular cancer

UW researcher reveals how cancer diagnosis affects employment, income of individuals and families

Study describes successful intervention to decrease breast cancer screening anxiety

University of Warwick, SYSUCC sign MoU to create cancer research partnership

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News